Novartis AG (NYSE:NVS) Q4 2020 Earnings Conference Call January 26, 2021 8:00 AM ET
Company Participants
Samir Shah - Investor Relations
Vas Narasimhan - Chief Executive Officer
Marie-France Tschudin - President, Novartis Pharmaceuticals
Susanne Schaffert - President, Novartis Oncology
Harry Kirsch - Chief Financial Officer
John Tsai - Head, Global Drug Development and Chief Medical Officer
Conference Call Participants
Mark Purcell - Morgan Stanley
Laura Sutcliffe - UBS
Matthew Weston - Credit Suisse
Steve Scala - Cowen
Graham Parry - Bank of America
Emmanuel Papadakis - Deutsche Bank
Richard Parkes - Exane BNP
Simon Baker - Redburn
Kerry Holford - Berenberg
Peter Welford - Jefferies
Keyur Parekh - Goldman Sachs
Emily Hutchinson - Citi
Seamus Fernandez - Guggenheim
Richard Vosser - JPMorgan
Florent Cespedes - Societe Generale
Naresh Chouhan - Intron
Emily Field - Barclays
Samir Shah
Thanks and good morning and good afternoon to everybody and thank you for taking the time to join us on this Q4 and Full Year Results Presentation. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Please refer to the company’s Form 20-F on file with the U.S. Securities and Exchange Commission for a description of some of these factors. And thank you again for joining us and I will hand across to Vas Narasimhan. Vas?
Vas Narasimhan
Thank you, Samir. I also wanted to say thank you all for joining today’s conference call. If we move to Slide 3, with me today, I have a number of my ECN colleagues, Harry, Susanne, Marie-France, John Tsai, Richard and Shannon and will be available to take your questions and also will be joining me for parts of the presentation.
- Read more current NVS analysis and news
- View all earnings call transcripts